TY - JOUR
T1 - Local and systemic vasodilatory effects of low molecular weight S-nitrosothiols
AU - Liu, Taiming
AU - Schroeder, Hobe J.
AU - Wilson, Sean M.
AU - Terry, Michael H.
AU - Romero, Monica
AU - Longo, Lawrence D.
AU - Power, Gordon G.
AU - Blood, Arlin B.
N1 - Publisher Copyright:
© 2015 Elsevier Inc. All rights reserved.
PY - 2016/2
Y1 - 2016/2
N2 - S-nitrosothiols (SNOs) such as S-nitroso-L-cysteine (L-cysNO) are endogenous compounds with potent vasodilatory activity. During circulation in the blood, the NO moiety can be exchanged among various thiol-containing compounds by S-transnitrosylation, resulting in SNOs with differing capacities to enter the cell (membrane permeability). To determine whether the vasodilating potency of SNOs is dependent upon membrane permeability, membrane-permeable L-cysNO and impermeable S-nitroso-D-cysteine (D-cysNO) and S-nitroso-glutathione (GSNO) were infused into one femoral artery of anesthetized adult sheep while measuring bilateral femoral and systemic vascular conductances. L-cysNO induced vasodilation in the infused hind limb, whereas D-cysNO and GSNO did not. L-cysNO also increased intracellular NO in isolated arterial smooth muscle cells, whereas GSNO did not. The infused SNOs remained predominantly in a low molecular weight form during first-passage through the hind limb vasculature, but were converted into high molecular weight SNOs upon systemic recirculation. At systemic concentrations of ∼0.6 μmol/L, all three SNOs reduced mean arterial blood pressure by ∼50%, with pronounced vasodilation in the mesenteric bed. Pharmacokinetics of L-cysNO and GSNO were measured in vitro and in vivo and correlated with their hemodynamic effects, membrane permeability, and S-transnitrosylation. These results suggest local vasodilation by SNOs in the hind limb requires membrane permeation, whereas systemic vasodilation does not. The systemic hemodynamic effects of SNOs occur after equilibration of the NO moiety amongst the plasma thiols via S-transnitrosylation.
AB - S-nitrosothiols (SNOs) such as S-nitroso-L-cysteine (L-cysNO) are endogenous compounds with potent vasodilatory activity. During circulation in the blood, the NO moiety can be exchanged among various thiol-containing compounds by S-transnitrosylation, resulting in SNOs with differing capacities to enter the cell (membrane permeability). To determine whether the vasodilating potency of SNOs is dependent upon membrane permeability, membrane-permeable L-cysNO and impermeable S-nitroso-D-cysteine (D-cysNO) and S-nitroso-glutathione (GSNO) were infused into one femoral artery of anesthetized adult sheep while measuring bilateral femoral and systemic vascular conductances. L-cysNO induced vasodilation in the infused hind limb, whereas D-cysNO and GSNO did not. L-cysNO also increased intracellular NO in isolated arterial smooth muscle cells, whereas GSNO did not. The infused SNOs remained predominantly in a low molecular weight form during first-passage through the hind limb vasculature, but were converted into high molecular weight SNOs upon systemic recirculation. At systemic concentrations of ∼0.6 μmol/L, all three SNOs reduced mean arterial blood pressure by ∼50%, with pronounced vasodilation in the mesenteric bed. Pharmacokinetics of L-cysNO and GSNO were measured in vitro and in vivo and correlated with their hemodynamic effects, membrane permeability, and S-transnitrosylation. These results suggest local vasodilation by SNOs in the hind limb requires membrane permeation, whereas systemic vasodilation does not. The systemic hemodynamic effects of SNOs occur after equilibration of the NO moiety amongst the plasma thiols via S-transnitrosylation.
KW - Membrane permeability
KW - Nitric oxide
KW - S-nitrosothiol
KW - S-transnitrosylation
KW - Vasodilation
KW - Molecular Weight
KW - Cells, Cultured
KW - Myocytes, Smooth Muscle/drug effects
KW - Nitric Oxide/metabolism
KW - Muscle, Smooth, Vascular/cytology
KW - Vasodilation/drug effects
KW - Vasodilator Agents/pharmacology
KW - Animals
KW - Cysteine/analogs & derivatives
KW - S-Nitrosothiols/pharmacology
KW - Sheep
KW - Drug Evaluation, Preclinical
UR - http://www.scopus.com/inward/record.url?scp=84952329927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952329927&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/806cbc25-81c4-39a0-a416-86f015e50452/
U2 - 10.1016/j.freeradbiomed.2015.12.009
DO - 10.1016/j.freeradbiomed.2015.12.009
M3 - Article
C2 - 26686469
SN - 0891-5849
VL - 91
SP - 215
EP - 223
JO - Free Radical Biology and Medicine
JF - Free Radical Biology and Medicine
ER -